Background: Telomere length (TL) shortens over time in most human cell types and is a potential biomarker aging. However, the causal impact of TL on physical and cognitive phenotypes that decline with age has not been extensively examined. Using a Mendelian randomization (MR) approach, we utilized genetically increased TL (GI-TL) to estimate the impact of TL on aging-related traits among UK Biobank (UKB) participants. Methods: We manually curated >50 aging-related traits from UKB and restricted to unrelated participants of British ancestry (n=337,522). We estimated GI-TL as a linear combination of nine TL-associated SNPs, each weighted by its previously-reported association with leukocyte TL. Regression models were used to assess the associations between GI-TL and each trait. We obtained MR estimates using the two-sample inverse variance weighted (IVW) approach. Results: We identified 5 age-related traits associated with GI-TL (Bonferroni-corrected threshold p<0.001): pulse pressure (PP) (p=5.2x10 -14 ), systolic blood pressure (SBP) (p=2.9x10 -15 ), diastolic blood pressure (DBP) (p=5.5x10 -6 ), forced expiratory volume (FEV1) (p= p=0.0001), and forced vital capacity (FVC) (p=3.8x10 -6 ). Under MR assumptions, one standard deviation increase in TL (~1200 base pairs) increased PP, SBP, and DBP by 1.5, 2.3, and 0.8 mmHg, respectively, while FEV1 and FVC increased by 34.7 and 52.2 mL, respectively. The observed associations appear unlikely to be due to selection bias based on analyses including inverse probability weights and analyses of simulated data. Conclusions: These findings suggest that longer TL increases pulmonary function and blood pressure traits. Further research is necessary to evaluate TL in cardiovascular and pulmonary age-related decline.
INTRODUCTION.
Telomeres are DNA-protein complexes that protect the ends of chromosomes from degradation and fusion. The DNA component, a 6-nucleotide repeat sequence, shortens with each cell division. 1 Thus, telomere length (TL) decreases as human age in most cell types 2 and is a proposed biomarker and potential cause of biologic aging. 3 Meta-analyses of observational studies of leukocyte TL suggest that TL is associated with allcause mortality, 4 and risks for age-related chronic diseases including cardiovascular disease, 5 type II diabetes, 6 Alzheimer's disease, 7 and some cancers. 8 These meta-analyses acknowledge that there is substantial heterogeneity across studies due to differences in TL measurement, study design, and adjustment for confounding factors, potentially affecting the validity of these associations.
Epidemiological studies of TL are susceptible to biases caused by confounding factors such as technical variation in TL measurement, environment, lifestyle, and cell type composition. Mendelian randomization (MR) is an alternative approach for estimating the impact of TL on disease susceptibility and utilizes genetic variants (SNPs) associated with leukocyte TL rather than measured TL itself, potentially avoiding biases caused by confounding factors and reverse causation. 9 Providing certain assumptions are satisfied, SNPs associated with TL can be used to estimate the non-confounded causal relationship between TL and a health outcome.
These assumptions include 1) the SNPs are associated with TL, 2) SNPs only affect the outcome via its effect on TL, and 3) SNPs are not associated with confounders that influence both TL and the outcome. 10 SNPs associated with leukocyte TL have been identified in prior genome-wide association studies (GWAS). [11] [12] [13] The ENGAGE consortium identified seven SNPs independently associated with TL, five of which were located in regions containing genes involved in telomere regulation and maintenance. 11 Several prior studies have applied MR approaches by utilizing genetic determinants TL to assess the potential causal contribution of TL to overall and cause-specific mortality, 14 the risk of cancer, 15 and non-communicable diseases. 16 While the biological basis for the role of TL in cellular aging is apparent, we do not know if variation in TL contributes to systemic aging of specific organ systems and the extent to which TL is causally related to age-related physical and cognitive decline. To address this question, we estimated genetically increased TL (GI-TL) and assessed its association with >50 agingrelated traits in 337,522 unrelated UK Biobank (UKB) participants of British ancestry. Using a MR approach, we then estimated causal associations between TL and these traits using SNP summary statistics from the ENGAGE consortium and UKB cohort (Figure 1 ).
METHODS.
Study Sample. The UKB cohort is a prospective study of ~500,000 middle-aged adults from the UK aged 40-69 years (recruited from 2006-2010). Postal invitations to participate were mailed to >9 million people registered with the UK National Health Service, who resided within 40 km of one of the 22 assessment centers. 17 Of the adults invited, 5.45% responded and participated. 18 At baseline, participants completed touchscreen questionnaires, physical exams, and verbal interviews, and a blood sample was obtained. All participants were genotyped at ~800,000
SNPs on either the custom UK BiLEVE Axiom Array or UK Biobank Axiom Array, with the two arrays sharing 95% of SNPs. Further information related to array design, genotyping, imputation, and quality control is summarized elsewhere. 19 We restricted our analysis to unrelated individuals with both self-reported and genetically predicted British ancestry based on the principal component (PC) analysis of genotypes. Our final sample size was 337,522 participants.
Curation of Age-related Traits from UKB. We searched the UKB data showcase to manually curate a set of aging-related traits from the cognitive function, physical measures, and self-reported touchscreen questionnaire variables to capture the following domains of health (at baseline): cardiovascular, pulmonary, anthropometric, physical activity, sensory (hearing and eyesight), oral, musculoskeletal, pain and general health. Among the physical measurement variables, we extracted traits related to blood pressure (BP), arterial stiffness, spirometry, anthropometry, bone density, and hand grip strength. We utilized summarized cognitive function variables to capture traits related to visual memory, fluid intelligence, and short-term memory, as described in Bakrania et al. 20 The remaining aging-related traits were extracted from the selfreported touchscreen questionnaire, and these traits included those related to pain, weight change, activity, fractures, oral health, hearing loss, eyesight, and general health. We extracted a total of 52 aging-related traits.
Derivation of Frailty Index. Frailty indices (FI) have been proposed to capture the variation in health among aging individuals. We applied the algorithm proposed by Williams et al to compute a FI for each participant. 21 Briefly, 49 self-reported questionnaire variables related to health, disease, disability, and mental wellbeing were extracted and coded into binary (0 or 1) or ordinal variables (values ranging from 0 to 1). For each UKB participant, FI was computed from the sum of the observations across these 49 variables and divided by 49 and expressed as a percent.
For participants with missing data for one or more variables, values for missing observations were imputed using multiple imputation by chained equations. 22 Estimation of Genetically Increased TL (GI-TL). We identified SNPs associated with leukocyte TL from prior genome-wide meta-analyses. [11] [12] [13] We selected nine SNPs that were associated with leukocyte TL and not in linkage disequilibrium with each other (see Table 1 ). For each SNP, we extracted the association estimate (i.e., beta coefficient and standard error) corresponding to the impact of a one allele increase on leukocyte TL in terms of the standard deviation (SD) (~1200 base pairs (bp)) from the ENGAGE telomere consortium. 11 GI-TL was estimated as a weighted linear combination of the TL-associated SNPs, corresponding to the sum of the weighted values for each SNP (∑
GI-TL was interpreted
as the additional TL relative to an arbitrary TL value, corresponding to GI-TL=0. 23, 24 A hypothetical individual with zero "long" TL alleles will have a GI-TL=0, corresponding to no additional bp of TL, while a hypothetical individual with 18 "long" TL alleles will have a GI-TL=1.08, corresponding to ~1296 additional bp of TL (compared to an individuals with zero "long" alleles) ( Figure S1 ).
Statistical Analysis. Each aging-related trait was expressed as a binary or continuous variable.
For individuals taking BP medication at baseline, we added 15 mmHg and 10 mmHg to their baseline systolic (SBP) and diastolic (DBP) BP, respectively, 25 and averaged first and second measurements. Hypertension was defined as >140 mmHg SBP or >90 mmHg DBP or selfreported BP medication use. For continuous variables we removed outlying or implausible values for SBP, DBP, forced expiratory volume (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF1), and pulse rate. We computed waist to hip ratio from waist and hip measurements, pulse pressure (PP) from the difference between SBP and DBP, and FV-ratio of FEV1 to FVC. We computed genotyping PCs among the selected UKB participants using EIGENSOFT [26] [27] [28] implemented in PLINK 1.9.
Logistic or linear multivariable regression models were utilized to estimate associations for each aging-related trait with GI-TL. We conducted analyses stratified by gender and median age (< or ≥ 58 years). A Bonferroni correction was applied to account for multiple testing at α =0.05. We utilized Cox proportional hazards models to estimate the association between GI-TL and mortality. Follow-up began when the participant conducted their baseline assessment and ended at whichever happened first: death, departure from study, or censoring date (November 30, 2015). All analyses included the following covariates: age, sex, and ten genotyping PCs.
Mendelian Randomization Analysis. We used a two-sample inverse-weighted variance (IVW)
approach to obtain estimates of the effect of TL on aging-related traits, as described previously. 9, 29 For each SNP included in the GI-TL score (k=9 SNPs), the beta coefficient (X k ) and its standard error (se) were obtained from the summary statistics from the GWAS of leukocyte TL from the ENGAGE consortium, and the per allele association estimate (Y k ) and its se (ߪ ೖ ) with the aging-related trait were obtained from the UKB cohort. The IVW MR estimate and its se were computed as follows:
All MR analyses were executed using the MendelianRandomization package in R. 30 We compared the MR-estimates from IVW to MR-estimates obtained from the maximum likelihood 9, 31 and weighted median 32 Inverse Probability Weighting. Selection can be a form of collider bias in MR studies when confounders are present. Selection into the study based on the outcome or/and the risk factor of interest can bias the MR effect estimate (Figure S2) , potentially violating the assumption that the instrumental variable and confounder(s) are marginally independent. 35, 36 UKB participants are more likely to be female, healthier, older, and of higher social and economic status than the target source population. 18 We applied an inverse probability weighting (IPW) approach to create a pseudo-population that is unaffected by selection on factors like age, sex, smoking status, and BP, 37 in order to estimate the average causal effect of TL (on BP and pulmonary traits) in the general population. 36 We computed IPWs as follows, using the percent of the source population belonging to a particular group based on a set of characteristics (up to four levels: i,j,k,l) and the percent of UKB participants belonging to that group:
ሻ ቇ
Using Web Table 1 38 We fit linear models adjusted for age, sex and 10 genotyping PCs and included IPWs as weights.
Simulated Datasets to Examine the Impact of Selection Bias on TL and SBP. We conducted simulations to examine how selection on TL, SBP (the strongest association identified), and/or confounders influenced the MR estimates under the hypothesis of no causal effect (β x =0) and of a true effect (based on the observed association) (β x =0.12). Using an approach similar to that described by Gkatzionis and Burgess, 36 we generated the risk factor, TL, (X i ) as a linear combination of a genetic risk score, a confounder, and an independent error term (see equation SNPs associated with TL, and PVE in TL by the confounder that we assumed (α 2 u =0.5).
(1)
We generated the outcome, SBP, using a linear combination of the risk factor (X i ), generated in equation 1, confounder, and an independent error term (see equation 2), where the random error term is drawn from Ν (0,1) distribution. The non-varying parameters included PVE explained by confounders in SBP that we assumed (β 2 u =0.50), and the causal effect to be estimated (β x =0 or β x =0.12).
For each simulated observation, a selection probability was generated and assigned 0 (not selected) or 1 (selected) based on a Bernoulli trial with that selection probability. We examined two functions to generate the selection probability: the risk factor effect on selection (see equation 3) and the outcome effect on selection (see equation 5). We varied the following parameters within the selection probability: the effect of risk factor on selection (γ x ), the effect of outcome on selection (γ y ), and the confounder effect on selection (γ u ) (see Appendix S1). We also included the baseline prevalence of selection into the UKB (γ 0 =0.0545).
Risk factor effect on selection:
Outcome effect on selection:
For each simulated dataset, we generated a random sample of 10,000,000 observations, similar to the size of the UKB source population. Among the observations with S=1, we randomly selected 500,000 observations. To obtain the causal effect estimate of the risk factor on the outcome, we conducted linear regressions of the genetic instrument (gene) on the risk factor (X) and the genetic instrument (gene) on the outcome (Y), and then, computed the ratio estimate and its se. We ran 1000 simulations per scenario and extracted the mean, median, SD, median se of the ratio estimates.
All analyses were performed in R 3.4.3.
RESULTS.
We analyzed 52 aging-related traits among the 337,522 UKB participants. The median age of participants included was 58 years (range: 39 to 72 years), and there were more women (53.7%) than men. Fifteen aging-related traits were associated with GI-TL at a significance threshold p=0.05 ( Table 2) , but only five traits surpassed the Bonferroni-corrected significance threshold (p<0.001) (Figure 2) . GI-TL was associated with better pulmonary and Figure S4) , with interaction p-values of 0.05 and 0.07, respectively.
Half of the UKB participants were defined as hypertensive (50.1%), and age was correlated with SBP (Pearson's r=0.332), DBP (r=0.071), and PP (r=0.418). We observed that p=5.2x10 -14 ) per one SD increase in TL. GI-TL was positively associated with SBP, PP, and DBP among both men and women, and there was not strong evidence that these associations differed by sex (Table S1 ). When we stratified by median age (< or >= 58 years), GI-TL was positively associated with SBP, PP, and DBP within both strata (Table S2) .
Among our study participants, 9196 deaths occurred before December 2015, and GI-TL was not associated with overall mortality, death from ischemic heart disease (n=1053), cerebrovascular disease (n=327), or chronic lower respiratory disease (n=227) ( In an exploratory sensitivity analysis, we sought to examine whether our results were influenced by the selection bias related to participation in the UKB cohort. To do this, we applied IPWs in linear regression models to examine the association between GI-TL and the five significant aging-related traits (see Methods). When we applied IPWs based on age only (derived from the UKB source population), we observed that the associations were slightly attenuated but still highly significant between GI-TL and SBP (β=2. per one SD increase in TL, respectively (Figure 3 and Table S5 ). For three out of the nine SNPs, the "long TL" allele was positively associated with FVC: TERC (β=9.2 mL, 95% CI Figure 4) . SBP was positively associated with eight of the nine TL-associated SNPs while DBP was only positively associated with three of the nine SNPs (p<0.05). DBP was not strongly associated with either the TERT or TERC SNPs (p>0.05).
Six of the nine TL-associated SNPs were positively associated with PP (p<0.05).
In addition to the IVW MR method, we also obtained MR estimates using several alternative MR approaches (Table S5 ). For both BP and the pulmonary traits, the maximum likelihood approach yielded similar MR-estimates and p-values. Using MR-Egger, the estimated intercept differed from zero for SBP (p=0.001), suggesting potential bias in the MR-estimate.
However, the MR-estimates obtained from the weighted median approach were similar to IVW for all traits. When we applied the MR-PRESSO test to identify horizontal pleiotropic outliers, NAF1 and DCAF4 were identified as outliers for SBP and PP (p<0.05), however, the removal the outliers increased the IVW MR-estimates for both traits.
In datasets simulated under the null hypothesis of no causal effect (β=0), selection on a continuous outcome (such as SBP) did not introduce bias or affect the false positive rate ( Table  1 S6). However, strong selection on a risk factor (e.g. TL) increased the false positive rate and biased the MR-estimate away from the null, with the direction of the bias depending on the direction of the confounder effects (Table S7) . Notably, this selection would have to be extremely strong (e.g. y x =-2 or y x =2) in order to generate the association of the magnitude we observe between TL and SBP (β x =0.12). Under the alternative hypothesis of a true effect between SBP and TL (β x =0.12), selection on the outcome attenuated causal effect estimate but did not decrease the empirical power to detect a true association of this magnitude between SBP and TL (Table S8) . When there was selection on the risk factor (again under the alternative hypothesis with β x =0.12), two different scenarios were observed (Table S9) . First, if the confounder effect on the risk factor and the outcome was in the same direction, then selection on the risk factor attenuated the association between SBP and TL and decreased the empirical power when there was also selection on the confounder (y u =-1 or y u =1). Second, if the confounder effect on the risk factor and outcome were in opposite directions, then strong selection on the risk factor biased the association between SBP and TL upward (similar in nature to the bias observed in Table S7 ).
DISCUSSION.
In this work, we examined the association between GI-TL and >50 aging-related traits among the UKB participants of British ancestry. While most aging-related traits did not
show clear associations with GI-TL, we observed positive associations for GI-TL with pulmonary function and BP traits. MR results suggest that longer TL is causally related to increased BP (SBP, DBP, and PP) and pulmonary function (FEV1 and FVC). Additionally, the associations of GI-TL with FEV1 and FVC were stronger among older UKB participants, suggesting longer TL may protect against age-related pulmonary decline.
Compared to our results, prior studies have observed similar associations between TL and pulmonary function. Among 46,396 Danish individuals, higher FEV1 and FVC was associated with longer measured TL. 40 A meta-analysis of 14 European studies identified positive associations between measured TL and FEV1 and FVC. 41 While FEV1 and FVC have not been examined in MR studies of TL, a large MR study of TL found evidence for an effect of long TL on decreased risk of interstitial lung disease (similar to IPF). 16 IPF is a hallmark of telomeropathy syndromes, characterized by very short TL due to mutations in telomere maintenance genes, such as TERT and TERC. 42, 43 The relationship between TL and pulmonary diseases indicates that TL may be a biologically important factor that contributes to the agerelated decline of pulmonary function.
Prior studies have observed inconsistent associations between TL and BP traits, with several null results reported. [44] [45] [46] [47] [48] [49] SBP was positively associated with measured TL in adult NHANES participants with SBP above 140 mmHg, 50 in Costa Rican elderly adults, 51 and in Australian adults 40-44 years. 52 DBP was inversely associated with measured TL in NHANES 50 and Costa Rican elderly adults. 51 In Danish population-based cohorts, longer measured TL was inversely associated with SBP while more TL "shortening" alleles were associated with decreased SBP. 14 Correspondingly, the percent of individuals with hypertension decreased with increasing TL "shortening" alleles. 53 The opposite associations between GI-TL and measured TL for BP traits suggest that these potential differences may be due to residual confounding (due to biologic, technical, and/or environmental effects) and/or biologic pleiotropy related to GI-TL.
Our analysis has several strengths and limitations. The UKB sample size is very large, which is critical for precise MR-based estimation. UKB also has a uniform and rigorously collected set of aging-related traits. GI-TL is constructed based on several SNPs that are near genes with clear relevance to TL biology, making GI-TL an instrumental variable with strong biological connection to TL. However, a central limitation of MR is that it is not possible to completely rule out the possibility of biologic pleiotropy between our TL-associated SNPs and aging-related traits. An additional limitation is the non-representativeness of the UKB sample, potentially reducing the external validity of our results; this limitation we attempted to address using simulated data and IPWs. We utilized IPWs to create pseudo-populations that are unaffected by selection on certain factors and more closely resemble the UKB source population. While all association estimates remained highly significant after the inclusion of IPWs, the association between GI-TL and BP traits slightly decreased and the association between GI-TL and pulmonary traits increased, suggesting that IPWs should be further explored for other characteristics that may influence participation (e.g. pulmonary function) and further developed for large cohorts such as UKB to enhance the validity and reliability of MR estimates.
From our analysis of simulated data to examine selection as a source of collider bias, we concluded that neither selection on the outcome (e.g. SBP) nor on the risk factor (e.g. TL) were likely to explain our observed MR association between TL and SBP. While we cannot create IPWs based on TL, selection on TL would have to be very strong to produce the observed association (under the null hypothesis of no effect), which in our view is not a biologically plausible explanation for the observed associations. These results based on simulated data were consistent with what was observed in the simulations reported by Gkatzionis and Burgess. 36 In conclusion, among unrelated UKB participants of British ancestry, GI-TL was associated with increased pulmonary function but also with higher BP. These findings provide evidence for a causal relationship between TL and these aging-related traits. Future longitudinal studies should evaluate age-related temporal changes in pulmonary function and BP traits and how these related to TL.
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